Axion BioSystems

CytoSMART Technologies is a specialist in the development and manufacturing of live-cell imaging systems for life science laboratories. Our goal is to support your next discovery. Axion builds flexible products that keep pace with your research while striving to test the limits of your imagination. SLAS New Product Award 2016 – Maestro APEX and Lumos Optical Stimulation system.

Our products enable live imaging of organoids, spheroids and model embryos (e.g. Our technology offers easy sample mounting and the possibility to image tens of sample in parallel, This makes our light sheet series the system of choice for long-term live imaging of 3D samples.

Nanolive offers a unique solution to live cell imaging and analysis that enables long term monitoring of live cells from the level of cell population down to their individual organelles. We are applying our technology to new research areas such as cell therapy manufacturing, regenerative medicine QA/QC and biotechnology. Nanolive offers a unique solution to live cell imaging that enables long term monitoring of live cells from the level of cell population down to their individual organelles. At Nanolive, we focus on innovative product development at the highest standards to deliver a high precision and quality research device for our international customers. Found out here more about Nanolive’s top applications. Our solutions are accelerating the drug discovery and development workflows of leading biopharma companies, transforming immuno-oncology, pathway discovery, mitochondrial & cell metabolism analysis, and sensitive cell line analytics. Online event – What makes Nanolive’s approach to holotomography unique? Online event – What can we learn from label-free cell images using Nanolive’s AI-powered analysis?

Cytomos is the trailblazing, investor-backed innovator behind AuraCyt™ technology. Cytomos is a purpose and impact driven organisation that is successfully repurposing microelectronics to enable the cost-effective use of biotechnologies and allow economies of scale. Our mission is to become the undisputed PAT partner for real-time-single-cell analytics. AuraCyt™ from Cytomos is harnessing the combined power of dielectric spectroscopy and consumer microelectronics to generate multidimensional data for single cells, without the need for labels. AuraCyt™ was developed by an in-house team, and we are continuing to work on a number of proof-of-concept studies in partnership with exciting large biotechs and pharma companies who see the value in this novel technology. With huge potential for applications across a range of markets, we are continuing to engage with well-known force multipliers in the bioprocessing and cell and gene therapy space, including bioprocessing solution market leaders and cutting-edge TechBio partners set to dominate the Advanced Therapy and Medical Products (ATMP) space, who see the ease of use and positive impact that AuraCyt™ is having on their work. AuraCyt™ will accelerate biological drug discovery and development, and it will streamline manufacturing, with real-time monitoring and better prospects for automation.

Microscopy Innovations is dedicated to understanding and meeting the needs of microscopists. The programmable ASP-1000 and ASP-2000 Automated Specimen Processors provide “walk-away” preparation of specimens and grids for greater lab efficiency and productivity of electron microscopy workflows.

LUMICKS is a next-generation life science tools company focused on enabling more efficient research, drug development, bioprocessing, bioproduction quality control, and patient treatment. Our products utilize our proprietary dynamic single-molecule (DSM) analysis and cell-binding avidity (CA) analysis technologies. We are an international team exceeding 200 people with more than 30 nationalities. We are proud of our great sense of ownership with the mentality of being open-minded in teamwork. LUMICKS is managed by an experienced team with diverse backgrounds. LUMICKS is the leading supplier of dynamic single-molecule and cell avidity analysis instruments. Our goal is to advance science and improve human health by providing tools that unlock the measurement of forces and interactions in biology to provide unparalleled insight into the fundamental cause of disease and the potential for drug optimization. We designed our instruments to provide rapid, in vitro confirmation of the mode of action and effectiveness of an immunotherapy product, thereby enabling the prediction of efficacy and side-effects in the lab before the product enters in vivo models.